News

Two UCSF Professors Elected to National Academy of Sciences

Two UCSF Professors Elected to National Academy of Sciences

May 6, 2014

An eminent cancer researcher and former director of the UCSF Helen Diller Family Comprehensive Cancer Center, and a leading professor of immunology have been selected as members of the National Academy of Sciences – one of the highest honors that can be accorded an American scientist – in recognition of their distinguished and continuing achievements in original research.

Acupuncture Helps Pediatric Patients Manage Pain and Nausea

Acupuncture Helps Pediatric Patients Manage Pain and Nausea

April 30, 2014

UCSF is One of Few  Academic Medical Centers to Offer Treatment to Inpatients and Outpatients.

Overlooked Cells Hold Keys to Brain Organization and Disease, UCSF Study Shows

Overlooked Cells Hold Keys to Brain Organization and Disease, UCSF Study Shows

April 29, 2014

Scientists studying brain diseases may need to look beyond nerve cells and start paying attention to the star-shaped cells known as "astrocytes," because they play specialized roles in the development and maintenance of nerve circuits and may contribute to a wide range of disorders, according to a new study by UC San Francisco researchers.

UCSF Health Disparities Leader Honored as 2014 Woman of the Year

UCSF Health Disparities Leader Honored as 2014 Woman of the Year

April 28, 2014

Dr. Rena Pasick, Professor of Medicine and Assistant Director, Community Education & Outreach at the UCSF Helen Diller Family Comprehensive Cancer Center, has been selected by the Women Health Care Executives (WHCE) as their 2014 Woman of the Year.  

Pancreatic Cancer

Pancreatic Cancer "Dream Team" Tackles Baffling, Deadly Disease

April 8, 2014

UC San Francisco has been selected to join a national "dream team" on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.

New Breast Cancer Results Illustrate Promise and Potential of I-SPY 2 Trial

New Breast Cancer Results Illustrate Promise and Potential of I-SPY 2 Trial

April 7, 2014

In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.